RESUMO
Various polydopamine (PDA) nanospheres were synthesized by utilizing triblock copolymer Pluronic F127 and 1,3,5-trimethylbenzene (TMB) as soft templates. Precise morphology control of polydopamine nanospheres was realized from solid polydopamine nanospheres to hollow polydopamine nanospheres, mesoporous polydopamine nanospheres and hollow mesoporous polydopamine nanospheres (H-MPDANSs) by adjusting the weight ratio of TMB to F127. The inner diameter of the prepared H-MPDANSs can be controlled in the range of 50-100 nm, and the outer diameter is about 180 nm. Furthermore, the thickness of hollow mesoporous spherical shell can be adjusted by changing the amount of dopamine (DA). The H-MPDANSs have good biocompatibility, excellent photothermal properties, high drug loading capacity, and outstanding sustainable drug release properties. In addition, both NIR laser irradiation and acid pH can facilitate the controlled release of doxorubicin (DOX) from H-MPDANSs@DOX.
Assuntos
Materiais Biocompatíveis/química , Portadores de Fármacos/química , Indóis/química , Nanosferas/química , Polímeros/química , Materiais Biocompatíveis/síntese química , Materiais Biocompatíveis/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Doxorrubicina/química , Doxorrubicina/metabolismo , Portadores de Fármacos/síntese química , Portadores de Fármacos/toxicidade , Liberação Controlada de Fármacos , Sinergismo Farmacológico , Eritrócitos/citologia , Eritrócitos/efeitos dos fármacos , Eritrócitos/metabolismo , Células HeLa , Hemólise/efeitos dos fármacos , Humanos , Microscopia Eletrônica de Transmissão , Tamanho da Partícula , Poloxâmero/química , PorosidadeRESUMO
Intracerebral hemorrhage (ICH) is a devastating disease worldwide with increasing mortality. The present study investigated whether minocycline was neuroprotective and induced M2 microglial polarization via upregulation of the TrkB/BDNF pathway after ICH. ICH was induced via injection of autologous blood into 150 Sprague-Dawley rats. A selective TrkB antagonist [N2-2-2-oxoazepan-3-yl amino] carbonyl phenyl benzo (b) thiophene-2-carboxamide (ANA 12)] and agonist [ N-[2-(5-hydroxy-1H-indol-3-yl) ethyl]-2-oxopiperidine-3-carboxamide (HIOC)] were used to investigate the mechanism of minocycline-induced neuroprotection. Minocycline improved ICH-induced neurological deficits and reduced M1 microglia marker protein (CD68, CD16) expression as well as M2 microglial polarization (CD206 and arginase 1 protein). Minocycline administration enhanced microglia-neuron cross talk and promoted the proliferation of neuronal progenitor cells, such as DCX- and Tuj-1-positive cells, 24 h after ICH. Minocycline also increased M2 microglia-derived brain-derived neurotrophic factors (BDNF) and the upstream TrkB pathway. ANA 12 reversed the neuroprotective effects of minocycline. HIOC exhibited the same effects as minocycline and accelerated neurogenesis after ICH. This study demonstrated for the first time that minocycline promoted M2 microglia polarization via upregulation of the TrkB/BDNF pathway and promoted neurogenesis after ICH. This study contributes to our understanding of the therapeutic potential of minocycline in ICH. NEW & NOTEWORTHY The present study gives several novel points: 1) Minocycline promotes neurogenesis after intracerebral hemorrhage in rats. 2) Minocycline induces activated M1 microglia into M2 neurotrophic phenotype. 3) M2 microglia secreting BDNF remodel the damaged neurocircuit.
Assuntos
Fator Neurotrófico Derivado do Encéfalo/metabolismo , Hemorragia Cerebral/prevenção & controle , Microglia/efeitos dos fármacos , Minociclina/administração & dosagem , Neurogênese/efeitos dos fármacos , Fármacos Neuroprotetores/administração & dosagem , Receptor trkB/metabolismo , Animais , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/fisiopatologia , Hemorragia Cerebral/fisiopatologia , Proteína Duplacortina , Aprendizagem em Labirinto/efeitos dos fármacos , Microglia/metabolismo , Ratos Sprague-Dawley , Transdução de Sinais/efeitos dos fármacos , Regulação para CimaRESUMO
OBJECTIVE: To study the inhibitory activities of 3-trifluoromethyl benzamide derivatives against the entry of H5N1 influenza viruses. METHODS: The lead compound was structurally modified to obtain 3 compounds with inhibitory activities against H5N1 influenza viruses. Specs compound librany was screened and 4 compounds were identified to have such inhibitory activities. The inhibitory activities of these compounds were tested at a celluar level against H5N1 influenza viruses. RESULTS AND CONCLUSION: The compounds 1a, 1b, 1e and 1f showed signifcant inhibitory activities against the entry of A/AnHui/1/2005 pseudovirus into the target cells with an IC50 value of 4.7 ± 0.3 µmol/L.
Assuntos
Antivirais/farmacologia , Benzamidas/farmacologia , Virus da Influenza A Subtipo H5N1/efeitos dos fármacos , Internalização do Vírus/efeitos dos fármacos , Humanos , Virus da Influenza A Subtipo H5N1/fisiologia , Influenza HumanaRESUMO
To explore the dependences of polyaniline (PANI) morphology on the oxidant and the initial pH value (referred to as 'pH-initial') of the reaction system, a series of oxidative polymerization experiments on aniline using chloroaurate acid (HAuCl4) as the oxidant are carried out in aqueous solutions with different values of pH-initial. The smooth morphology transition of PANI nanostructures from nanofibers to solid and hollow nanospheres can be controlled by simply changing pH-initial for the reaction solution using HAuCl4 as the oxidant. In aqueous solutions with different values of pH-initial, the anilinium ions and neutral aniline molecules coexist in different proportions, leading to different PANI nanostructures under different nucleation mechanisms. In strongly acidic media (pH-initial < 2), the homogeneous nucleation of PANI will result in PANI nanofibers. When pH-initial is raised to 2 or above, the heterogeneous nucleation will lead to solid or hollow PANI nanospheres. The solid PANI nanospheres are obtained in mildly acidic media (pH-initial=2-4) and the diameter decreases as the initial pH value of the reaction solution increases from 2 to 4. However, in weakly acidic and neutral media (pH-initial=5-7), hollow PANI nanospheres are formed and the diameter increases with the increase of pH-initial for the solution from 5 to 7.
Assuntos
Compostos de Anilina/química , Nanofibras/química , Nanosferas/química , Cloretos/química , Compostos de Ouro/química , Concentração de Íons de Hidrogênio , Nanofibras/ultraestrutura , Nanosferas/ultraestrutura , Oxidantes/química , OxirreduçãoRESUMO
We reported previously that a small molecule named CL-385319 could inhibit H5N1 influenza virus infection by targeting hemagglutinin, the envelope protein mediating virus entry. In the present study, a novel series of derivatives focused on the structural variation of CL-385319 were synthesized as specific inhibitors against the H5 subtype of influenza A viruses. These small molecules inhibited the low pH-induced conformational change of hemagglutinin, thereby blocking viral entry into host cells. Compound 1l was the most active inhibitor in this series with an IC(50) of 0.22 µM. The structure-activity relationships analysis of these compounds showed that the 3-fluoro-5-(trifluoromethyl)benzamide moiety was very important for activity, and the -F group was a better substituent group than -CF(3) group in the phenyl ring. The inhibitory activity was sensitive to the benzamide because the oxygen and hydrogen of the amide served as H-bond acceptor and donor, respectively.
Assuntos
Antivirais/síntese química , Benzamidas/síntese química , Glicoproteínas de Hemaglutininação de Vírus da Influenza/metabolismo , Virus da Influenza A Subtipo H5N1/efeitos dos fármacos , Fusão de Membrana/efeitos dos fármacos , Piperidinas/síntese química , Animais , Antivirais/farmacologia , Benzamidas/farmacologia , Cães , Genes Reporter , Células HEK293 , Humanos , Hidrogênio/química , Ligação de Hidrogênio , Concentração de Íons de Hidrogênio , Virus da Influenza A Subtipo H5N1/crescimento & desenvolvimento , Virus da Influenza A Subtipo H5N1/metabolismo , Luciferases , Células Madin Darby de Rim Canino , Oxigênio/química , Piperidinas/farmacologia , Relação Estrutura-Atividade , Transfecção , Internalização do Vírus/efeitos dos fármacosRESUMO
The influenza glycoprotein hemagglutinin (HA) plays crucial roles in the early stage of virus infection, including receptor binding and membrane fusion. Therefore, HA is a potential target for developing anti-influenza drugs. Recently, we characterized a novel inhibitor of highly pathogenic H5N1 influenza virus, CL-385319, which specifically inhibits HA-mediated viral entry. Studies presented here identified the critical binding residues for CL-385319, which clustered in the stem region of the HA trimer by site-directed mutagenesis. Extensive computational simulations, including molecular docking, molecular dynamics simulations, molecular mechanics generalized Born surface area (MM_GBSA) calculations, charge density and Laplacian calculations, have been carried out to uncover the detailed molecular mechanism that underlies the binding of CL-385319 to H5N1 influenza virus HA. It was found that the recognition and binding of CL-385319 to HA proceeds by a process of "induced fit" whereby the binding pocket is formed during their interaction. Occupation of this pocket by CL-385319 stabilizes the neutral pH structure of hemagglutinin, thus inhibiting the conformational rearrangements required for membrane fusion. This "induced fit" pocket may be a target for structure-based design of more potent influenza fusion inhibitors.
Assuntos
Antivirais/química , Glicoproteínas de Hemaglutininação de Vírus da Influenza/química , Hidrocarbonetos Fluorados/química , Virus da Influenza A Subtipo H5N1/química , Piperidinas/química , Substituição de Aminoácidos/genética , Antivirais/metabolismo , Antivirais/farmacologia , Benzamidas , Estabilidade de Medicamentos , Glicoproteínas de Hemaglutininação de Vírus da Influenza/genética , Glicoproteínas de Hemaglutininação de Vírus da Influenza/metabolismo , Humanos , Hidrocarbonetos Fluorados/metabolismo , Hidrocarbonetos Fluorados/farmacologia , Virus da Influenza A Subtipo H5N1/genética , Fusão de Membrana/efeitos dos fármacos , Simulação de Acoplamento Molecular , Simulação de Dinâmica Molecular , Mutação , Piperidinas/metabolismo , Piperidinas/farmacologia , Ligação Proteica , Estabilidade Proteica , Relação Estrutura-AtividadeRESUMO
Theaflavins are the major components of tea polyphenols in brewed black tea. We previously reported that theaflavin derivatives, such as TF3, inhibited HIV-1 entry by targeting gp41. However, it is difficult to purify the individual theaflavins and the purified compounds are highly unstable. To develop theaflavins as affordable anti-HIV-1 microbide for preventing HIV sexual transmission, we intended to use an economic natural preparation containing 90% of theaflavins (TFmix). Its antiviral activity against HIV-1 strains was evaluated in vitro using p24 production and luciferase assays. The mechanism by which TFmix inhibits HIV-1 infection was investigated using time-of-addition, cell-cell fusion and biophysical assays. The data suggested TFmix exhibited potent anti-HIV-1 activity on lab-adapted and primary HIV-1 strains with IC(50) less than 1.20 µM. It also effectively inhibited infection by T-20 resistant HIV-1 strains. The mechanism studies suggest that TFmix mainly inhibit the HIV-1 entry by targeting gp41 since it is effective in inhibiting gp41 six-helix bundle (6-HB) formation and HIV-1 envelope protein-mediated cell-cell fusion. TFmix could also inhibit HIV-1 reverse transcriptase (RT) activity, but the IC(50) is about 8-fold higher than that for inhibiting gp41 6-HB formation, suggesting RT is not a major target for TFmix. In conclusion, TFmix is an economic natural product preparation containing high content of theaflavins with potent anti-HIV-1 activity by targeting the viral entry step through the disruption of gp41 6-HB core structure. It has a potential to be developed as a safe and affordable topical microbicide for preventing sexual transmission of HIV.
Assuntos
Fármacos Anti-HIV/farmacologia , Biflavonoides/farmacologia , Catequina/farmacologia , Infecções por HIV/prevenção & controle , HIV-1/efeitos dos fármacos , Preparações de Plantas/farmacologia , Chá/química , Fármacos Anti-HIV/química , Fármacos Anti-HIV/isolamento & purificação , Biflavonoides/química , Biflavonoides/isolamento & purificação , Catequina/química , Catequina/isolamento & purificação , Linhagem Celular , Sobrevivência Celular , Estabilidade de Medicamentos , Infecções por HIV/virologia , Transcriptase Reversa do HIV/efeitos dos fármacos , Transcriptase Reversa do HIV/metabolismo , HIV-1/fisiologia , Humanos , Concentração de Íons de Hidrogênio , Fusão de Membrana/efeitos dos fármacos , Preparações de Plantas/química , Preparações de Plantas/isolamento & purificação , Proteínas Virais/efeitos dos fármacos , Proteínas Virais/metabolismo , Internalização do Vírus/efeitos dos fármacosRESUMO
CL-385319, an N-substituted piperidine, is effective in inhibiting infection of H1-, H2-, and to a lesser extent, H3-typed influenza A viruses by interfering with the fusogenic function of the viral hemagglutinin. Here we show that CL-385319 is effective in inhibiting infection of highly pathogenic H5N1 influenza A virus in Madin-Darby Canine Kidney (MDCK) cells with an IC50 of 27.03±2.54 µM. This compound with low cytotoxicity (CC50=1.48±0.01 mM) could also inhibit entry of pseudoviruses carrying hemagglutinins from H5N1 strains that were isolated from different places at different times, while it had no inhibitory activity on the entry of VSV-G pseudotyped particles. CL385319 could not inhibit N1-typed neuraminidase activity and the adsorption of H5-typed HA to chicken erythrocytes at the concentration as high as 1 mg/ml (2.8 mM). Computer-aid molecular docking analysis suggested that CL-385319 might bind to the cavity of HA2 stem region which was known to undergo significant rearrangement during membrane fusion. Pseudoviruses with M24A mutation in HA1 or F110S mutation in HA2 were resistant to CL-385319, indicating that these two residues in the cavity region may be critical for CL-385319 bindings. These findings suggest that CL-385319 can serve as a lead for development of novel virus entry inhibitors for preventing and treating H5N1 influenza A virus infection.
Assuntos
Antivirais/farmacologia , Hidrocarbonetos Fluorados/farmacologia , Virus da Influenza A Subtipo H5N1/efeitos dos fármacos , Virus da Influenza A Subtipo H5N1/fisiologia , Piperidinas/farmacologia , Internalização do Vírus/efeitos dos fármacos , Animais , Antivirais/metabolismo , Antivirais/toxicidade , Benzamidas , Cães , Células HEK293 , Glicoproteínas de Hemaglutininação de Vírus da Influenza/química , Glicoproteínas de Hemaglutininação de Vírus da Influenza/metabolismo , Humanos , Hidrocarbonetos Fluorados/metabolismo , Hidrocarbonetos Fluorados/toxicidade , Virus da Influenza A Subtipo H5N1/metabolismo , Modelos Moleculares , Piperidinas/metabolismo , Piperidinas/toxicidade , Conformação ProteicaRESUMO
OBJECTIVE: To investigate the inhibitory activities of caffeoyl glucopyranoses purified from Balanophora japonica Makino on HIV entry and their mechanism. METHODS: HIV-1 Env pseudovirus was used to evaluate the anti-HIV-1 activity of those compounds. ELISA and molecular docking were used to study the mechanism of the actions of the active compounds. RESULTS: We used the HIV-1 Env pseudovirus to test the anti-HIV-1 activity of the six phenolic compounds (final concentration 25 microg/ml), and found that only 1,2,6-Tri-O-caffeoyl-beta-D-glucopyranose (TCGP) and 1,3-Di-O-caffeoyl-4-O-galloyl-beta-D- glucopyranose (DCGGP) could effectively inhibit the entry of HIV-1 Env pseudovirus into the target cells in a dose-dependent manner, with IC(50) values of 5.5-/+0.2 and 5.3-/+0.1 microg/ml, respectively. These two compounds could also blocked the gp41 six-helix bundle formation. Molecular docking analysis suggested that they might bind to the hydrophobic cavity of the gp41 N-trimeric coiled-coil. CONCLUSION: TCGP and DCGGP are potent HIV-1 entry inhibitors targeting gp41 and can serve as lead compounds for developing novel anti-HIV-1 microbicides for prevention of sexual HIV-1 transmission.
Assuntos
Fármacos Anti-HIV/farmacologia , Balanophoraceae/química , HIV-1/efeitos dos fármacos , Extratos Vegetais/farmacologia , Linhagem Celular , Ácido Gálico/análogos & derivados , Ácido Gálico/farmacologia , Glucose/análogos & derivados , Glucose/farmacologia , Humanos , Taninos Hidrolisáveis/farmacologiaRESUMO
Seasonal influenza epidemics and influenza pandemics caused by influenza A virus (IAV) has resulted in millions of deaths in the world. The development of anti-IAV vaccines and therapeutics is urgently needed for prevention and treatment of IAV infection and for controlling future influenza pandemics. Hemagglutinin (HA) of IAV plays a critical role in viral binding, fusion and entry, and contains the major neutralizing epitopes. Therefore, HA is an attractive target for developing anti-IAV drugs and vaccines. Here we have reviewed the recent progress in study of conformational changes of HA during viral fusion process and development of HA-based antiviral therapeutics and vaccines.
Assuntos
Antivirais/uso terapêutico , Hemaglutininas/fisiologia , Vírus da Influenza A/imunologia , Vacinas contra Influenza/imunologia , Epidemias , Humanos , Influenza Humana/imunologia , Influenza Humana/terapia , PandemiasRESUMO
OBJECTIVE: To investigate the effects of the total saponin of Psidium guajava leaf (TSGL) on HIV-1 envelop proteins (env) mediated virus entry into target cells. METHODS: The TSGL was purified and concentrated using SA-1 macropore resin. The effect of TSGL on HIV-1 entry into target cells was tested using a cell-cell fusion assay by mixing CHO-WT and MT-2 cells. The cytotoxicity of TSGL was measured by MTT assay. The activity of TSGL on blocking the HIV-1 gp41 six helical bundle (6-HB) formation was analyzed by ELISA and Native-PAGE (N-PAGE). RESULTS: The TSGL could inhibit HIV env mediated cell-cell fusion with an IC50 of (7.33 +/- 0.40) microg/mL, and displayed little cytotoxicity at that concentration. ELISA assay showed that the TSGL could prevent gp41 6-HB formation with inhibitory activity of 95.93% at 25 microg/mL. N-PAGE study confirmed the inhibitory effect of TSGL on gp41 6-HB formation. CONCLUSIONS: The TSGL can inhibit HIV entry target cells by interfering the envelop subunit gp41 form the critical 6-HB structure.
Assuntos
Proteína gp41 do Envelope de HIV/efeitos dos fármacos , Inibidores da Fusão de HIV/farmacologia , HIV-1/efeitos dos fármacos , Psidium/química , Saponinas/farmacologia , Fusão Celular , Linhagem Celular , Relação Dose-Resposta a Droga , Ensaio de Imunoadsorção Enzimática , Proteína gp41 do Envelope de HIV/química , Proteína gp41 do Envelope de HIV/metabolismo , Inibidores da Fusão de HIV/administração & dosagem , HIV-1/fisiologia , Humanos , Testes de Sensibilidade Microbiana , Folhas de Planta/química , Saponinas/administração & dosagem , Internalização do Vírus/efeitos dos fármacosRESUMO
OBJECTIVE: To study the mechanism underlying the inhibitory effect of the anti-HIV peptide VIR576 on antigen-specific T cell activation. METHODS: CCK-8 assay was used to investigate the effect of VIR576 on the proliferation of splenocytes of OVA-specific DO11.10 Tg mice in response to chicken OVA. Hemolysis test, hemolysis inhibition assay and fluorescence binding assay were used to investigate the interaction of VIR576 with the transmembrane domain (TMD) of the T cell receptor (TCR). RESULTS: VIR576 inhibited HIV glycoprotein gp41 fusion peptide-mediated antigen specific T cell activation, and VIR576 itself also inhibited splenocyte proliferation in responses to OVA (P<0.05). Hemolysis test, hemolysis inhibition assay and fluorescence binding assay demonstrated that VIR576 suppressed TCR-TMD-mediated hemolysis and competitively inhibited Rho-VIR576 binding to TCR-TMD peptide. CONCLUSION: VIR576 is effective in suppressing the antigen-specific T cell activation via TCR and can interact with TCR-TMD. VIR576 may serve as a potent microbicide candidate to block sexual transmission of HIV due to of its inhibitory effect on both HIV entry and antigen-specific T cell activation.